|
KR960701653A
(ko)
|
1993-03-29 |
1996-03-28 |
발라수브라마니암 엠비카이파칸 |
펩타이드 yy의 유사체 및 그의 용도
|
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
|
CA2271788A1
(en)
|
1996-11-13 |
1998-05-22 |
University Of Cincinnati |
Analogs of peptide yy and uses thereof
|
|
EP0908515A3
(en)
|
1997-09-16 |
2000-04-26 |
Smithkline Beecham Plc |
Pancreatic polypeptide
|
|
US6046167A
(en)
|
1998-03-25 |
2000-04-04 |
University Of Cincinnati |
Peptide YY analogs
|
|
EP1086078B1
(en)
|
1998-06-08 |
2003-02-05 |
Schering Corporation |
Neuropeptide y5 receptor antagonists
|
|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
|
EP2123293A3
(en)
|
2000-12-14 |
2010-09-08 |
Amylin Pharmaceuticals, Inc. |
Peptide YY and petide YY agonists for treatment of metabolic disorders
|
|
US6589938B2
(en)
|
2001-06-29 |
2003-07-08 |
National University Of Singapore |
Use of angiotensin I derivatives as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders
|
|
CN100350968C
(zh)
|
2001-09-24 |
2007-11-28 |
皇家创新有限公司 |
饮食行为的改进
|
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
|
WO2004066966A2
(en)
|
2003-01-17 |
2004-08-12 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Peptide yy analogs
|
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
|
BR122019021416A2
(enExample)
|
2003-09-19 |
2019-12-21 |
|
|
|
CN100444898C
(zh)
|
2003-09-19 |
2008-12-24 |
诺沃挪第克公司 |
治疗肽的清蛋白结合型衍生物
|
|
EP1667724A2
(en)
|
2003-09-19 |
2006-06-14 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
EP1696962A2
(en)
|
2003-12-18 |
2006-09-06 |
Novo Nordisk A/S |
Novel glp-1 analogues linked to albumin-like agents
|
|
NZ579621A
(en)
|
2004-02-11 |
2011-03-31 |
Amylin Pharmaceuticals Inc |
Hybrid polypeptides with selectable properties
|
|
US8603969B2
(en)
|
2004-02-11 |
2013-12-10 |
Amylin Pharmaceuticals, Llc |
Pancreatic polypeptide family motifs and polypeptides comprising the same
|
|
EP2060266B1
(en)
|
2004-03-17 |
2011-08-10 |
7TM Pharma A/S |
Y4 selective receptor agonist PP2-36 for therapeutic interventions
|
|
US20090186811A1
(en)
|
2004-03-17 |
2009-07-23 |
Thue Schwartz |
Y2 Selective Receptor Agonists for Therapeutic Interventions
|
|
EA011860B1
(ru)
|
2004-03-17 |
2009-06-30 |
7ТиЭм ФАРМА А/С |
Селективные агонисты рецептора y2 для терапевтического воздействия
|
|
JP2007531714A
(ja)
|
2004-03-17 |
2007-11-08 |
７ティーエム ファーマ エイ／エス |
治療的介入のためのｙ２／ｙ４選択性レセプターアゴニスト
|
|
GB0412181D0
(en)
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
|
CA2572770A1
(en)
|
2004-07-08 |
2006-01-19 |
Novo-Nordisk A/S |
Polypeptide protracting tags comprising a tetrazole moiety
|
|
WO2006020207A2
(en)
|
2004-07-19 |
2006-02-23 |
University Of Cincinnati |
Compounds for control of appetite
|
|
WO2006049681A2
(en)
|
2004-08-30 |
2006-05-11 |
Bayer Pharmaceuticals Corporation |
Selective neuropeptide y2 receptor agonists
|
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
WO2007008778A2
(en)
|
2005-07-11 |
2007-01-18 |
Nastech Pharmaceutical Company Inc. |
Formulations for enhanced mucosal delivery of pyy
|
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
|
AU2005337116A1
(en)
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y4 selective receptor agonists for therapeutic interventions
|
|
ATE516301T1
(de)
|
2005-09-21 |
2011-07-15 |
7Tm Pharma As |
Y2-selektive rezeptoragonisten für therapeutische eingriffe
|
|
CA2630649A1
(en)
|
2005-12-07 |
2007-06-14 |
F. Hoffmann-La Roche Ag |
Neuropeptide-2 receptor-agonists
|
|
JP2009519296A
(ja)
|
2005-12-14 |
2009-05-14 |
ノボ・ノルデイスク・エー／エス |
ポリペプチド延長タグ
|
|
US20070197445A1
(en)
|
2006-01-18 |
2007-08-23 |
University Of Cincinnati |
Compounds for control of appetite
|
|
WO2007109354A2
(en)
|
2006-03-21 |
2007-09-27 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
GB0621973D0
(en)
|
2006-11-03 |
2006-12-13 |
Philogen Spa |
Binding molecules and uses thereof
|
|
US20090099074A1
(en)
|
2007-01-10 |
2009-04-16 |
Conjuchem Biotechnologies Inc. |
Modulating food intake
|
|
US20100022446A1
(en)
|
2007-01-18 |
2010-01-28 |
Novo Nordisk A/S |
Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
|
|
WO2008087186A2
(en)
|
2007-01-18 |
2008-07-24 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
GB0708226D0
(en)
|
2007-04-27 |
2007-06-06 |
7Tm Pharma As |
Y-receptor agonists
|
|
WO2009007714A2
(en)
|
2007-07-09 |
2009-01-15 |
Imperial Innovations Limited |
Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour
|
|
WO2009030771A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
AU2008303922A1
(en)
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of the peptide His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe alone or in combination with the peptide Gly-Ard-Gly-Asp-Asn-Pro-OH as a therapeutic agent
|
|
US8598314B2
(en)
|
2007-09-27 |
2013-12-03 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase-inhibitor conjugates and methods of making and using same
|
|
WO2009138511A1
(en)
|
2008-05-16 |
2009-11-19 |
Novo Nordisk A/S |
Long-acting y2 and/or y4 receptor agonists
|
|
US8299023B2
(en)
|
2008-09-17 |
2012-10-30 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists
|
|
GB0817067D0
(en)
|
2008-09-18 |
2008-10-22 |
7Tm Pharma As |
Intestinal treatment
|
|
CN102202681A
(zh)
|
2008-11-05 |
2011-09-28 |
霍夫曼-拉罗奇有限公司 |
神经肽-2受体(y-2r)激动剂及其用途
|
|
JP5584236B2
(ja)
|
2009-02-20 |
2014-09-03 |
イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ |
神経ペプチドｙ受容体結合化合物を有する細胞毒性コンジュゲート
|
|
WO2011033068A1
(en)
*
|
2009-09-18 |
2011-03-24 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
JP2013507414A
(ja)
|
2009-10-13 |
2013-03-04 |
エフ．ホフマン−ラ ロシュ アーゲー |
神経ペプチド−２受容体（ｙ−２ｒ）アゴニスト
|
|
EP2498800A1
(en)
|
2009-11-13 |
2012-09-19 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
EP2560675A1
(en)
|
2010-04-20 |
2013-02-27 |
Novo Nordisk A/S |
Long-acting gastrin derivatives
|
|
CN102946875A
(zh)
|
2010-05-05 |
2013-02-27 |
贝林格尔.英格海姆国际有限公司 |
组合疗法
|
|
GB201101459D0
(en)
|
2011-01-27 |
2011-03-16 |
Imp Innovations Ltd |
Novel compounds and thier effects on fedding behaviour
|
|
US20150141336A1
(en)
|
2012-05-29 |
2015-05-21 |
Novo Nordisk A/S |
Pancreatic Peptide Compounds and Use
|
|
AU2014261111B2
(en)
|
2013-05-02 |
2017-03-16 |
Glaxosmithkline Intellectual Property Development Limited |
Therapeutic peptides
|
|
CN105722526B
(zh)
|
2013-11-15 |
2020-12-08 |
诺和诺德股份有限公司 |
选择性pyy化合物及其用途
|
|
TWI694082B
(zh)
|
2015-06-12 |
2020-05-21 |
丹麥商諾佛 儂迪克股份有限公司 |
選擇性ｐｙｙ化合物及其用途
|